Atrial fibrillation: a new ant arrhythmic drug

Atrial fibrillation , which affects merely in Italy at minimum 700 000 people, this time in the spotlight of drug discovery, All aimed at judgment busy more efficient and secure for treating this cardiac arrhythmia, which promises to gain and also to protect the serious consequences relative to it.

We have already mentioned some new products introduced beneath the final Congress cardiology including a new busy ingredient, acting anticoagulant during their find out against atrial fibrillation. But the news does not halt and is now that accessible also in Italy a new drug for the treatment of atrial fibrillation: the dromedaries. This busy ingredient is ant arrhythmic: works by increasing the time between a contraction of atrium the other, encouraging the consolidation and maintenance of common heart rhythm which, in this pathology is indeed altered.

The efficacy and protection of the drug were tried in the ATHENA learn , involving above 4600 patients ( recruited in 29 Italian centers well ) , whereby the dromedaries would result in those who suffer from atrial fibrillation, a reduction of 26 says risk hospitalization for cardiovascular problems and 16% risk demise. According to some other learn, also taking this new drug would be capable to compact by 34 says the risk of stroke.

The dromedaries were also included in the Guidelines of 2020 European Society of Cardiology Among the drugs of alternative for maintaining the sinus rhythm in all patients with paroxysmal and persistent atrial fibrillation. In Italy have been authorized by AIFA and its prescription are borne by the National Health System for patients with clinically steady adults with a history of atrial fibrillation or atrial fibrillation with non-permanent way.